Navigation Links
Gamma Knife Offers New Hope For Trigeminal Neuralgia Patients

There is now new hope on the horizon for trigeminal neuralgia patients as researchers have found that Gamma Knife Stereotactic Radiosurgery (GKRS) is an effective way to deal with the pain caused by the condition.//

Researchers at the Comprehensive Cancer Center at Wake Forest University Baptist Medical found that the GKRS technique relived pain to a considerable degree in a study of 400 patients who underwent the procedure at the center. The comprehensive findings of this study are to be presented at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in Denver. "This has proven to be a safe, effective treatment for trigeminal neuralgia patients, without the potential facial paralysis and long-term recovery experienced with conventional surgery," said Volker Stieber, M.D., co-director of the Gamma Knife Program at Wake Forest Baptist and lead researcher in the current study. GKRS is a non-invasive and an outpatient procedure which accomplishes the task of reducing pain by directing 201 narrow "pencil beams" of radioactive cobalt-60 into the affected area of the trigeminal nerve. Almost 90 percent of the patients reported significant reduction of pain after the procedure, while one-third reported that they experienced facial numbness. However, these patients said that the numbness was more tolerable than the pain.

Trigeminal neuralgia is an intensely painful condition that affects the fifth cranial nerve. This nerve is a major nerve of the face and transmits sensory as well as motor impulses from the area. The neuralgia also called tic douloureaux is triggered by touching some areas on the face called as 'trigger zones' such as the side of the face of the nose or even while brushing. Until now, the best way of treating the condition was sectioning the nerve, which was a risky procedure.
'"/>




Page: 1

Related medicine news :

1. Gamma Knife Offers Noninvasive Treatment for Vascular Disorders, Brain Tumors
2. A New Gamma Camera Technique for the Detection of Small Breast Tumors
3. Gamma Knife Offers Noninvasive Treatment for Vascular Disorders, Brain Tumors
4. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
5. Drug Offers Hope for Alzheimers disease
6. Drug Firm Offers to Donate Smallpox Vaccine
7. fMRI Offers Insight Into An Infants Brain
8. Gel Offers A More Targeted Approach
9. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
10. Surgery Offers Better Treatment For Third Degree Piles
11. New Study Offers Hope For Balding Men

Post Your Comments:
(Date:11/26/2009)...tions announces a highly effective and unconventio...g to make an economic recovery. , ... the type of challenge that could send ailing holi...David Benton, business growth expert and author of... The Rfactor Intensive . “Fear is one of ...
(Date:11/25/2009)...e-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: O...oreventsinDecember: ,, ASHBriefing ,, ...cipalinvestigatorswilldiscussdatapresentationssurr...lemyeloma,asfeaturedatthe51stAmericanSocietyofHema...LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a.m...
(Date:11/25/2009)...-USNewswire/--AnarticlebyJanetWoodcock,M.D.,direct...led"ADifficultBalance-PainManagement,DrugSafety,an...ndJournalofMedicine. ,, (Logo: http://www.newsc...article,WoodcockdiscussesFDAeffortstostrikeabalanc...managingtherisksposedbyvariousanalgesics.Asexample...
(Date:11/25/2009)... who were treated with cisplatin-based chemotherap...ical side effects and Raynaud-like phenomena, than...ding to a new study published online November 25 i..., Marianne Brydy, M.D., of the Department of Onc...orway, and colleagues conducted a cross-sectional ...
(Date:11/25/2009)...o draw definite conclusions, experts say, , ...iabetic patients with blocked coronary arteries, t...e year whether patients undergo bypass surgery or ...ort. , Bypass surgery has been the standard tre...disease. However, less invasive approaches such as...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...common, naturally occurring virus that attacks can...ls is being studied as a possible treatment for ma... called gliomas. Researchers at Cedars-Sinai Medic...the virus in its natural state. It commonly infect...
...and African plants are being used by Queensland re...o treat chronic pain. , Professor David Craik an...r Bioscience have received $218,275 from the Natio...he molecule they have developed have shown that it...
...mon and severe symptom reported by middle-aged wom... into the menopause, according to a study in the A...sing. , Researchers at the University of Arizona ...s. Their average age was 49 and they had all exper...
...Xinhua-PRNewswire-FirstCall/ --,China RuiTai Inter...RUI),(,China RuiTai, or ,the Company,), a leading ...ts in the People,s Republic of China (,PRC,),today...n -- Gross profit increased 33.4% to $11.9 millio...
...rience in both healthcare and human ...Precyse Solutions, the leader in,driving peak perf...,departments, today announced the appointment of K...f Human Resources,and Administration. With over 25...
...verwhelmingly want their next President to focus m...ng universal healthcare, and stemming the,outsourc...igrants to live,and work in the U.S., according to...ing of 1,125 working,Americans between April 4 and...
Other Medicine News:Health News:Cedars-Sinai Medical Center opens patient trial of virus that attacks brain cancer cells 2Health News:Cone snails and plants used to develop oral drug for pain 2Health News:Getting a good night's sleep is the biggest problem for women entering the menopause 2Health News:Getting a good night's sleep is the biggest problem for women entering the menopause 3Health News:China RuiTai Reports Fiscal Year 2007 Financial Results 2Health News:China RuiTai Reports Fiscal Year 2007 Financial Results 3Health News:China RuiTai Reports Fiscal Year 2007 Financial Results 4Health News:China RuiTai Reports Fiscal Year 2007 Financial Results 5Health News:China RuiTai Reports Fiscal Year 2007 Financial Results 6Health News:China RuiTai Reports Fiscal Year 2007 Financial Results 7Health News:China RuiTai Reports Fiscal Year 2007 Financial Results 8Health News:China RuiTai Reports Fiscal Year 2007 Financial Results 9Health News:Precyse Solutions Appoints Karen Heisler as New Corporate Vice President, Human Resources 2Health News:Americans Want Next President to Focus More on Saving U.S. Jobs and Healthcare; Less on Immigration Reform 2Health News:Americans Want Next President to Focus More on Saving U.S. Jobs and Healthcare; Less on Immigration Reform 3
(Date:11/25/2009)...therlandsandJOHANNESBURG,November25/PRNewswire/--,...overyannouncedtoday,thattheyhavesignedacollaborati... , Pyxis,sworldclasscomputationalchemistryand...ervicedivisiontoprovidemedicinaland,syntheticchemi...nationalclientnetwork.iThembaPharmaceuticalsandPyx...
(Date:11/24/2009)...Nov.24/PRNewswire/-- ,, WHAT:RomHoubens,aBelgia...toaccident,wasactuallyfullyconsciousandawakeduring...nt.TheDynaVoxEyeMaxwasfeaturedinthesegmenttoillust...nscanunlockcommunication. ,, WHEN:GoodMorningAm...w.dynavoxtech.com ,, WHO:RomHoubenswasaneng...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--AnadysPharmaceuticals,...atthe21stAnnualPiperJaffrayHealthcareConferenceonT...econferenceisbeingheldatTheNewYorkPalaceHotel.Stev...Anadys,willprovideanoverviewofAnadysanditsclinical...oratepresentationwillbesimultaneouslywebcastandcan...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 1Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 5WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 1WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 2WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 3Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3
Slimtine S
M 3.2 J Unipolar Atrial "J" Lead
VascoTip P 9/60 PU S
VascoTip P 9/60 M
Medicine Products: